Rocket Lab Corp RKLB

Rocket Lab Corp spent the quarter to 31 March 2026 paying heavily for its future and saying so on the record. The company reported revenue of $200.3M, a net loss attributable to the parent of $45.0M, and an operating loss of $56.0M, all from its latest 10-Q on SEC EDGAR. Diluted loss per share came to $0.07 across 605.4M diluted weighted-average shares.

The business is an equity in the space and launch sector, and the supplied evidence frames it as a research-intensive operator rather than a finished cash machine. Research and development expense was $80.5M in the quarter, roughly forty per cent of revenue, the line where a launch and space-systems company funds the programmes it hopes will pay later. Why it matters is simple: the income statement is shaped by that spend, and the cash balance is what carries it.

On the balance sheet, the same 10-Q (period ending 2026-03-31) shows assets of $2.82B, liabilities of $555.6M, stockholders' equity attributable to the parent of $2.26B, and cash and cash equivalents of $1.21B. Operating activities used $50.3M of cash, capital expenditure on property, plant and equipment was $27.1M, and inventory rose $24.6M to $183.1M. Those figures describe a lightly levered company funding capacity and stock from its own balance sheet.

The source rail here is SEC filings, not a chart route or a launch manifest, so this file rests on documents rather than candles or price levels. No chart context was supplied, and no segment revenue, backlog, or launch cadence has been parsed into the evidence; the market mechanism on view is filing flow into SEC EDGAR, where the 10-Q, the 8-Ks and the insider forms all land.

What changed in May and June is governance and capital access. An 8-K filed 2026-05-20 records an Equity Distribution Agreement under which sales agents earn a commission not exceeding 2.00% per share for selling stock over time, an at-the-market channel against the 605.4M diluted share count. An 8-K filed 2026-05-21 notes stockholders approved a subsidiary merger to remove a pass-through voting provision at the wholly owned operating arm. An 8-K filed 2026-06-05 confirms an executive, Ricupati, will be eligible for the Executive Severance Plan, alongside a Form 3 and several Form 4 insider filings on 2026-06-05 and another Form 4 on 2026-06-18.

What remains unproven from this evidence is the operating trajectory: whether revenue grows against the R&D and capex, whether the inventory build converts to deliveries, and whether the ATM is ever drawn. The file would deepen with a fresh 10-Q showing the next revenue print, segment detail, and cash-flow direction, or an 8-K naming a specific contract or programme milestone rather than a governance change.